Eden Research (LON:EDEN) Stock Price Down 4.7% – Should You Sell?

Eden Research plc (LON:EDEN)’s share price was down 4.7% on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.43 ($0.04). Approximately 291,737 shares changed hands during mid-day trading, a decline of 69% from the average daily volume of 928,598 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a market capitalization of £18.29 million, a price-to-earnings ratio of -12.02 and a beta of 0.92. The stock’s 50 day moving average price is GBX 3.88 and its 200 day moving average price is GBX 3.95. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26.

Insider Activity at Eden Research

In other Eden Research news, insider Lykele van der Broek bought 256,000 shares of the firm’s stock in a transaction on Thursday, February 6th. The shares were purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,975.16). Also, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,396.86). 14.02% of the stock is owned by company insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.